We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Olympus

Manufactures optical and digital equipment for the healthcare and consumer electronics sectors, including endoscopy a... read more Featured Products: More products

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Next-Gen Electrosurgical Generator Enhances Efficiencies in Treatment of Bladder Cancer and Enlarged Prostate

By HospiMedica International staff writers
Posted on 07 Jun 2023
Print article
Image: The ESG-410 next generation electrosurgical generator (Photo courtesy of Olympus)
Image: The ESG-410 next generation electrosurgical generator (Photo courtesy of Olympus)

Bladder cancer remains a significant global health issue and the leading contributor to cancer-related deaths worldwide. As the tenth most common cancer globally, it also ranks as the second most prevalent urinary tract malignancy, resulting in around 549,000 new cases and approximately 200,000 deaths each year. Despite its widespread occurrence, advanced bladder cancer treatment options remain scarce. In addition, benign prostatic hyperplasia (BPH), a common issue affecting 50% of men between 51 and 60 and up to 90% of men over 80, further compounds urinary health concerns. Now, a new electrosurgical generator designed for use in the treatment of bladder cancer and enlarged prostate aims to improve patient outcomes by elevating the standard of care.

The new ESG-410 electrosurgical generator from Olympus (Center Valley, PA, USA) is designed to facilitate and streamline the treatment of non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia (BPH), or enlarged prostate. This device comes equipped with a range of resection loops, band electrodes, and vaporization buttons and needles. The ESG-410 electrosurgical generator and its accompanying accessories and ancillary equipment are intended for tissue cutting and coagulation in open, laparoscopic, and endoscopic surgeries. Compared to its predecessor, the ESG-400, the ESG-410 includes larger capacitors for improved plasma stability during ignition.

The ESG-410 generator requires less energy for ignition than its predecessor and enhances procedural efficiency in BPH resections due to its ability to reliably ignite larger resection loops, thereby accelerating tissue removal. The ESG-410 also outperforms the ESG-400 by offering quicker ignition and improved plasma stability, even without tissue contact, with large, medium, and band loops and oval buttons. It also features a larger 8.4" LCD touch screen and includes wireless foot pedals, providing a significant upgrade from the ESG-400.

Related Links:
Olympus

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
3D HD Video Recorder
HVO-3000MT

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.